ATE213943T1 - Verwendung von piperazin-acetamid-derivaten gegen reperfusionsschaden - Google Patents

Verwendung von piperazin-acetamid-derivaten gegen reperfusionsschaden

Info

Publication number: ATE213943T1
Authority: AT; Austria
Prior art keywords: piperazine; reperfusion damage; acetamide derivatives; derivatives against; against reperfusion
Prior art date: 1989-11-22

Application number

AT93201656T

Other languages

English (en)

Inventor

Belle Herman Van

Laerhoven Willy Johannes C Van

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-22

Filing date

1990-11-19

Publication date

2002-03-15

1990-11-19 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2002-03-15 Application granted granted Critical

2002-03-15 Publication of ATE213943T1 publication Critical patent/ATE213943T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A61K38/166—Streptokinase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Protection Of Pipes Against Damage, Friction, And Corrosion (AREA)
Dicing (AREA)
Golf Clubs (AREA)
Professional, Industrial, Or Sporting Protective Garments (AREA)
Suspension Of Electric Lines Or Cables (AREA)
Branch Pipes, Bends, And The Like (AREA)
Paper (AREA)
External Artificial Organs (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)

AT93201656T 1989-11-22 1990-11-19 Verwendung von piperazin-acetamid-derivaten gegen reperfusionsschaden ATE213943T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US44014289A	1989-11-22	1989-11-22
SG118494A SG118494G (en)	1989-11-22	1994-08-20	Method of preventing or limiting reperfusion damage

Publications (1)

Publication Number	Publication Date
ATE213943T1 true ATE213943T1 (de)	2002-03-15

Family

ID=26664237

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT93201656T ATE213943T1 (de)	1989-11-22	1990-11-19	Verwendung von piperazin-acetamid-derivaten gegen reperfusionsschaden
AT90917677T ATE102831T1 (de)	1989-11-22	1990-11-19	Verfahren zur verhuetung oder zur begrenzung einer reperfusionsschaedigung.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT90917677T ATE102831T1 (de)	1989-11-22	1990-11-19	Verfahren zur verhuetung oder zur begrenzung einer reperfusionsschaedigung.

Country Status (22)

Country	Link
EP (2)	EP0455789B1 (de)
JP (1)	JP2574585B2 (de)
KR (1)	KR0165686B1 (de)
AT (2)	ATE213943T1 (de)
AU (1)	AU632888B2 (de)
CA (1)	CA2044143C (de)
CY (1)	CY1869A (de)
DE (2)	DE69033926T2 (de)
DK (2)	DK0455789T3 (de)
ES (2)	ES2173883T3 (de)
FI (1)	FI109694B (de)
HK (1)	HK115095A (de)
HU (1)	HU215847B (de)
IE (1)	IE65121B1 (de)
IL (1)	IL96390A (de)
NO (2)	NO304519B1 (de)
NZ (1)	NZ236168A (de)
PT (2)	PT95959B (de)
RU (1)	RU2093156C1 (de)
SG (1)	SG118494G (de)
WO (1)	WO1991007967A2 (de)
ZA (1)	ZA909345B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9202266D0 (sv) *	1992-07-31	1992-07-31	Kabi Pharmacia Ab	Novel piperazine carboxamides
SE9504661D0 (sv)	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
RU2216549C2 (ru) *	1997-11-07	2003-11-20	Дайити Фармасьютикал Ко., Лтд.	Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс
US6683100B2 (en)	1999-01-19	2004-01-27	Novartis Ag	Organic compounds
US6194181B1 (en)	1998-02-19	2001-02-27	Novartis Ag	Fermentative preparation process for and crystal forms of cytostatics
SE9904674D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904673D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE0001209D0 (sv)	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
US6573264B1 (en) *	2000-10-23	2003-06-03	Cv Therapeutics, Inc.	Heteroaryl alkyl piperazine derivatives
PT1395567E (pt)	2001-05-18	2009-03-26	Astrazeneca Ab	Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203302D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
US20090018351A1 (en) *	2003-11-12	2009-01-15	Dr. Reddy's Laboratories, Inc.	Preparation of escitalopram
DK1781631T3 (da)	2004-08-02	2012-05-14	Astrazeneca Ab	Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
FR2946340B1 (fr)	2009-06-05	2011-06-24	Galderma Res & Dev	Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
KR101900124B1 (ko)	2014-06-25	2018-09-18	전남대학교산학협력단	전복 박리용 조성물
KR101644299B1 (ko)	2014-07-22	2016-08-02	주식회사 엔바이로젠	오미자 및 삼채 추출물을 유효성분으로 포함하는 전복 박리용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4766125A (en) *	1981-06-23	1988-08-23	Janssen Pharmaceutica N.V.	N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
NZ223847A (en) *	1987-04-01	1989-12-21	Janssen Pharmaceutica Nv	Substituted piperazine derivatives and pharmaceutical compositions

1990
- 1990-11-19 WO PCT/EP1990/001985 patent/WO1991007967A2/en not_active Ceased
- 1990-11-19 DE DE69033926T patent/DE69033926T2/de not_active Expired - Fee Related
- 1990-11-19 DK DK90917677.8T patent/DK0455789T3/da active
- 1990-11-19 IL IL9639090A patent/IL96390A/en not_active IP Right Cessation
- 1990-11-19 ES ES93201656T patent/ES2173883T3/es not_active Expired - Lifetime
- 1990-11-19 ES ES90917677T patent/ES2053208T3/es not_active Expired - Lifetime
- 1990-11-19 AU AU68763/91A patent/AU632888B2/en not_active Ceased
- 1990-11-19 AT AT93201656T patent/ATE213943T1/de not_active IP Right Cessation
- 1990-11-19 RU SU905001085A patent/RU2093156C1/ru active
- 1990-11-19 HU HU2436/91A patent/HU215847B/hu not_active IP Right Cessation
- 1990-11-19 JP JP3500097A patent/JP2574585B2/ja not_active Expired - Fee Related
- 1990-11-19 DK DK93201656T patent/DK0577171T3/da active
- 1990-11-19 DE DE69007471T patent/DE69007471T2/de not_active Expired - Fee Related
- 1990-11-19 AT AT90917677T patent/ATE102831T1/de not_active IP Right Cessation
- 1990-11-19 KR KR1019910700758A patent/KR0165686B1/ko not_active Expired - Fee Related
- 1990-11-19 EP EP90917677A patent/EP0455789B1/de not_active Expired - Lifetime
- 1990-11-19 CA CA002044143A patent/CA2044143C/en not_active Expired - Fee Related
- 1990-11-19 EP EP19930201656 patent/EP0577171B1/de not_active Expired - Lifetime
- 1990-11-20 NZ NZ236168A patent/NZ236168A/xx unknown
- 1990-11-21 ZA ZA909345A patent/ZA909345B/xx unknown
- 1990-11-21 IE IE420990A patent/IE65121B1/en not_active IP Right Cessation
- 1990-11-22 PT PT95959A patent/PT95959B/pt not_active IP Right Cessation
1991
- 1991-06-26 NO NO912511A patent/NO304519B1/no unknown
- 1991-07-16 FI FI913433A patent/FI109694B/fi active
1994
- 1994-08-20 SG SG118494A patent/SG118494G/en unknown
1995
- 1995-07-13 HK HK115095A patent/HK115095A/en not_active IP Right Cessation
1996
- 1996-04-05 CY CY186996A patent/CY1869A/xx unknown
1998
- 1998-04-20 PT PT102145A patent/PT102145B/pt not_active IP Right Cessation
- 1998-05-07 NO NO19982078A patent/NO311701B1/no unknown

Also Published As

Publication number	Publication date
ES2173883T3 (es)	2002-11-01
HU9102436D0 (en)	1991-12-30
FI109694B (fi)	2002-09-30
JP2574585B2 (ja)	1997-01-22
IE904209A1 (en)	1991-05-22
NO912511L (no)	1991-08-26
DK0577171T3 (da)	2002-06-03
CA2044143C (en)	2002-11-19
HUT58709A (en)	1992-03-30
ES2053208T3 (es)	1994-07-16
FI913433A0 (fi)	1991-07-16
IL96390A (en)	1995-06-29
SG118494G (en)	1994-11-25
NO912511D0 (no)	1991-06-26
EP0455789A1 (de)	1991-11-13
DE69033926D1 (de)	2002-04-11
DE69033926T2 (de)	2002-10-24
NO311701B1 (no)	2002-01-14
NO304519B1 (no)	1999-01-04
EP0577171A2 (de)	1994-01-05
DE69007471T2 (de)	1994-06-23
DE69007471D1 (de)	1994-04-21
IL96390A0 (en)	1991-08-16
PT95959B (pt)	1998-08-31
AU632888B2 (en)	1993-01-14
AU6876391A (en)	1991-06-26
PT102145B (pt)	2002-06-28
WO1991007967A2 (en)	1991-06-13
KR920700644A (ko)	1992-08-10
ZA909345B (en)	1992-08-26
PT102145A (pt)	1999-10-29
NO982078D0 (no)	1998-05-07
CY1869A (en)	1996-04-05
KR0165686B1 (ko)	1999-01-15
ATE102831T1 (de)	1994-04-15
EP0577171A3 (en)	1994-06-29
EP0455789B1 (de)	1994-03-16
PT95959A (pt)	1991-09-13
DK0455789T3 (da)	1994-04-05
HK115095A (en)	1995-07-21
NZ236168A (en)	1993-05-26
WO1991007967A3 (en)	1991-07-11
HU215847B (hu)	1999-04-28
NO982078L (no)	1991-08-26
CA2044143A1 (en)	1991-05-23
EP0577171B1 (de)	2002-03-06
RU2093156C1 (ru)	1997-10-20
IE65121B1 (en)	1995-10-04

Publication	Publication Date	Title
ATE213943T1 (de)	2002-03-15	Verwendung von piperazin-acetamid-derivaten gegen reperfusionsschaden
DK0734383T3 (da)	2002-10-14	Cykliske amidderivater som neurokinin-A-antagonister
FI850078A0 (fi)	1985-01-08	N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat.
FI901421A0 (fi)	1990-03-21	N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat.
RU93043528A (ru)	1996-09-20	Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
FI933391A0 (fi)	1993-07-29	Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning
DK74691A (da)	1991-04-23	4(4-(substitueret phenyl)-1-piperazinyl)phenoler og fremgangsmaade til fremstilling deraf
LV11689A (lv)	1997-02-20	4-Ú(2-benzotiazolil)metilamino¾-alfa-Ú(3,4-difluorfenoksi)metil¾-1-piperidinetanols
PT99251A (pt)	1992-08-31	Processo para a preparacao de derivados de piperazina
DE69226931D1 (de)	1998-10-15	Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten
NZ230854A (en)	1991-02-26	1,4 dihydropyridine derivatives, intermediate compound and pharmaceutical compositions
AU7586191A (en)	1991-12-31	Hydroxyproline derivative, a process for the preparation thereof and pharmaceutical compositions containing it
FI920945L (fi)	1993-09-04	Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi

Legal Events

Date	Code	Title	Description
2002-08-15	UEP	Publication of translation of european patent specification
2008-08-15	REN	Ceased due to non-payment of the annual fee